Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
In the age of AI, the ability to ask great questions is becoming more valuable than simply memorizing facts, says OpenAI CEO Sam Altman. Speaking on Adam Grant’s ReThinking podcast, Altman emphasized ...